Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …

Abstract The 2019 coronavirus disease (COVID-19) has become a global pandemic.
Several studies report that ABO blood group polymorphism may be related to COVID-19 …

Since the emergence of COVID-19, many publications have reported associations with ABO
blood types. Despite between-study discrepancies, an overall consensus has emerged …

Since the onset of the COVID-19 pandemic, a concentrated research effort has been
undertaken to elucidate risk factors underlying viral infection, severe illness, and death …

ABO blood group is long known to be an influencing factor for the susceptibility to infectious
diseases, and many studies have been describing associations between ABO blood types …

Background Numerous studies investigate the association between the ABO blood groups
and the occurrence of COVID-19 infection; discordant findings were reported. Therefore, the …

Aims One of the comorbidities associated with severe outcome and mortality of COVID-19 is
dyslipidemia. Statin is one of the drugs which is most commonly used for the treatment of …

Background There is little evidence on the relationship between statin use and the risk of
hospitalization attributable to COVID‐19. Methods and Results The French National …

We have been experiencing a global pandemic with baleful consequences for mankind,
since the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first …

Background Vaccination of patients with chronic kidney disease (CKD) and kidney
transplants (KTs) may achieve a less robust immune response. Understanding such immune …